Cured of Hepatitis C: Is There Potential to Infect Others?
Is your blood still infectious after being cured of Hepatitis C?
Continue reading »Is your blood still infectious after being cured of Hepatitis C?
Continue reading »Discover why having Hepatitis C could increase the odds of a successful liver transplant.
Continue reading »Find out why Germany's Boehringer Ingelheim has stopped development of faldepravir, its lead candidate in the HCV market.
Continue reading »Will cutting HCV treatment time down from 12 weeks to 4 weeks help reduce cost of this cure?
Continue reading »Although the virus itself does not discriminate against gender, these seven differences between men and women with Hepatitis C are worth reviewing.
Continue reading »Find out about hepatitis testing events in May, and locate organizations offering hepatitis testing near you.
Continue reading »In recognition of May being Hepatitis Awareness Month, the American Liver Foundation invites you to participate in a live webinar program, Hepatitis C: Treatment Options and the Patient Experience, on Wednesday, May 28.
Continue reading »Learn about the clinical data which suggests that interferon-free regimens containing Gilead's Sovaldi (sofosbuvir) and Bristol-Myers Squibb's NS5A inhibitor daclatasvir have advantages over currently available regimens for HCV genotype-3 infections.
Continue reading »Learn more about the combination of two anti-viral drugs (daclatasvir and asunaprevir) developed by Bristol-Myers Squibb Co that has been highly effective and well tolerated among study participants.
Continue reading »If you or a family member was recently diagnosed, this free webinar from the American Liver Foundation and the Chronic Liver Disease Foundation could be the educational resource you've been looking for.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window